Jens J. Holst

Specialty: Incretin Hormones

Location: Unknown

Tier: ELITE

H-Index: 160

Years Active: 0

Hospital Affiliations

• University of Copenhagen - Faculty

Key Publications

1. "Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist." - JCI Insight (2020)
2. "Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined." - N Engl J Med (2021)
3. "Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial." - Cardiovasc Diabetol (2023)
4. "Glucose-dependent insulinotropic polypeptide (GIP)." - Mol Metab (2025)
5. "The expanding incretin universe: from basic biology to clinical translation." - Diabetologia (2023)

Knowledge Graph Relationships

Jens J. Holst is a Incretin Hormones specialist affiliated with University of Copenhagen. Authored 5 scholarly articles.